Vera Therapeutics, Inc.
VERA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831828
In the last 90 days, Vera Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 219 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Vera Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 59
- +4 vs. Q3 2022
- Shares held
- 21.3M
- −207.2K (−1.0%) vs. Q3 2022
- Total value
- $412.8M
- −$46.3M (−10.1%) vs. Q3 2022
- New holders
- 10
- 23 more added
- Sold out
- 6
- 13 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VERA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 219 | $3.34B |
| Q1 2026 | 229 | $2.92B |
| Q4 2025 | 214 | $3.75B |
| Q3 2025 | 176 | $1.89B |
| Q2 2025 | 172 | $1.51B |
| Q1 2025 | 179 | $1.52B |
| Q4 2024 | 178 | $2.66B |
| Q3 2024 | 173 | $2.37B |
| Q2 2024 | 171 | $1.92B |
| Q1 2024 | 159 | $2.21B |
| Q4 2023 | 95 | $637.2M |
| Q3 2023 | 84 | $538.2M |
| Q2 2023 | 76 | $611.9M |
| Q1 2023 | 70 | $289.7M |
| Q4 2022 | 59 | $412.8M |
| Q3 2022 | 55 | $459.0M |
| Q2 2022 | 51 | $277.6M |
| Q1 2022 | 50 | $468.9M |
| Q4 2021 | 37 | $374.9M |
| Q3 2021 | 31 | $252.4M |
| Q2 2021 | 22 | $186.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Vera Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nisa Investment Advisors, LLC | 17 | $0 | 0.00% | +17 | New |
| Citigroup Inc | 467 | $9.04K | 0.00% | −783−62.6% | Reduced |
| Ameritas Investment Partners, Inc. | 1,061 | $9.69K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 531 | $10.0K | 0.00% | −1,004−65.4% | Reduced |
| UBS Group AG | 897 | $17.4K | 0.00% | −4,401−83.1% | Reduced |
| Metropolitan Life Insurance Co | 1,041 | $20.1K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 2,203 | $43.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2,533 | $49.0K | 0.00% | +1,862+277.5% | Added |
| Legal & General Group Plc | 5,906 | $114.3K | 0.00% | +520+9.7% | Added |
| Deutsche Bank AG | 6,348 | $122.8K | 0.00% | +92+1.5% | Added |
| American International Group, Inc. | 6,778 | $131.2K | 0.00% | +127+1.9% | Added |
| MetLife Investment Management | 8,881 | $171.8K | 0.00% | 00.0% | Unchanged |
| Gyon Technologies Capital Management, LP | 9,413 | $182.1K | 0.07% | −11,018−53.9% | Reduced |
| Credit Suisse AG | 9,558 | $184.9K | 0.00% | −109−1.1% | Reduced |
| Cambridge Trust Co | 9,887 | $191.0K | 0.01% | 00.0% | Unchanged |
| Walleye Trading LLC | 10,945 | $211.8K | 0.01% | +10,945 | New |
| New York State Common Retirement Fund | 11,013 | $213.1K | 0.00% | −30.0% | Reduced |
| Dimensional Fund Advisors LP | 11,498 | $223.0K | 0.00% | +11,498 | New |
| Barclays PLC | 13,279 | $256.9K | 0.00% | +3,254+32.5% | Added |
| State of Wisconsin Investment Board | 14,156 | $273.9K | 0.00% | −895−5.9% | Reduced |
| Morgan Stanley | 15,553 | $301.0K | 0.00% | −7,407−32.3% | Reduced |
| Carnegie Mellon University | 16,060 | $310.8K | 0.17% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 17,017 | $329.3K | 0.00% | +17,017 | New |
| Jump Financial, LLC | 17,600 | $340.6K | 0.02% | +17,600 | New |
| Ensign Peak Advisors, Inc | 17,816 | $344.7K | 0.00% | −3,300−15.6% | Reduced |
| Raymond James Financial Services Advisors, Inc. | 17,828 | $345.0K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 18,053 | $349.0K | 0.00% | +453+2.6% | Added |
| California State Teachers Retirement System | 18,697 | $361.8K | 0.00% | +362+2.0% | Added |
| Alps Advisors Inc | 18,749 | $362.8K | 0.00% | +4,005+27.2% | Added |
| Renaissance Technologies LLC | 24,900 | $482.0K | 0.00% | +24,900 | New |
| Moore Capital Management, LP | 25,000 | $483.8K | 0.01% | +25,000 | New |
| Pura Vida Investments, LLC | 35,372 | $684.4K | 0.11% | +35,372 | New |
| Swiss National Bank | 35,900 | $694.7K | 0.00% | +1,200+3.5% | Added |
| Charles Schwab Investment Management Inc | 38,859 | $751.9K | 0.00% | +969+2.6% | Added |
| Bank of America Corp | 51,676 | $999.9K | 0.00% | +17,279+50.2% | Added |
| Bank of New York Mellon Corp | 71,770 | $1.39M | 0.00% | +2,272+3.3% | Added |
| Nuveen Asset Management, LLC | 98,136 | $1.90M | 0.00% | +8,470+9.4% | Added |
| JPMorgan Chase & Co | 113,982 | $2.21M | 0.00% | +38,652+51.3% | Added |
| Northern Trust Corp | 125,481 | $2.43M | 0.00% | +10,611+9.2% | Added |
| Woodline Partners LP | 149,553 | $2.89M | 0.04% | −19,724−11.7% | Reduced |
| Walleye Capital LLC | 229,204 | $4.44M | 0.10% | +229,204 | New |
| State Street Corp | 256,696 | $4.97M | 0.00% | +6,913+2.8% | Added |
| Geode Capital Management, LLC | 257,066 | $4.97M | 0.00% | +17,266+7.2% | Added |
| International Biotechnology Trust PLC | 281,257 | $5.43M | 1.68% | 00.0% | Unchanged |
| Logos Global Management LP | 285,000 | $5.51M | 0.65% | +285,000 | New |
| Alphabet Inc. | 301,580 | $5.84M | 0.34% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 333,333 | $6.45M | 0.04% | 00.0% | Unchanged |
| Vivo Capital, LLC | 400,666 | $7.75M | 0.94% | −266,000−39.9% | Reduced |
| Eversept Partners, LP | 411,308 | $7.96M | 0.76% | +255,179+163.4% | Added |
| Polar Asset Management Partners Inc. | 414,000 | $8.01M | 0.11% | −109,400−20.9% | Reduced |
| Octagon Capital Advisors LP | 665,156 | $12.9M | 2.00% | +131,892+24.7% | Added |
| Vanguard Group Inc | 767,533 | $14.9M | 0.00% | +8,701+1.1% | Added |
| BlackRock Inc. | 875,884 | $16.9M | 0.00% | +85,089+10.8% | Added |
| Millennium Management LLC | 1,108,649 | $21.5M | 0.02% | +711,721+179.3% | Added |
| Kynam Capital Management, LP | 1,409,098 | $27.3M | 4.18% | −127,083−8.3% | Reduced |
| Citadel Advisors LLC | 1,991,473 | $38.5M | 0.04% | 00.0% | Unchanged |
| Abingworth LLP | 2,960,231 | $57.3M | 18.87% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 3,181,442 | $61.6M | 3.74% | 00.0% | Unchanged |
| FMR LLC | 4,148,646 | $80.3M | 0.01% | +92,305+2.3% | Added |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −1,578,820−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −121,000−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −5,183−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −1,600−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −231−100.0% | Sold out |